MONTPELLIER, France & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Regulatory News: Sensorion (FR001401A9Z0 – ALSEN) (“the Company”), a pioneering clinical-stage biotechnology company that develops novel therapies to restore hearing and to treat and prevent hearing loss disorders, today announced its participation in the 33rd European Society of Gene & Cell Therapy (ESGCT) Annual Congress, taking place on October 27-30, 2026, at the Congress Center Hamburg (CCH), in Hamburg, Germany. Lise Barrot, Pre